GlassScriptPhysician profile
James Norman Parrish
NPI 1477552503
$6,558.44
in general payments reported to CMS, 2019-2025
22 companies · $1,948 in 2025
The $1,948 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $160 · 2021: $66.54 · 2022: $578 · 2023: $1,519 · 2024: $1,979 · 2025: $1,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,825 · Travel and Lodging: $2,578 · Gift: $43.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,825.08 |
| Travel and Lodging | $2,577.79 |
| Gift | $43.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,358.97 | 2022-2025 | Da Vinci Surgical System |
| Ethicon US, LLC | $411.80 | 2019-2025 | Megadyne, Vistaseal |
| Medical Device Business Services, INC. | $230.30 | 2025 | Linx Reflux Management System |
| Novo Nordisk INC | $135.73 | 2023-2025 | Wegovy |
| Allergan, INC. | $54.31 | 2020-2021 | |
| Conmed Corporation | $50.00 | 2023 | Airseal |
| Solventum Corporation | $35.25 | 2024 | V.A.C. Veraflo, Prevena |
| Braintree Laboratories, INC. | $27.25 | 2019 | |
| Baxter Healthcare | $25.72 | 2020 | |
| Redhill Biopharma INC. | $24.64 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $21.55 | 2025 | Exparel |
| Kerecis Limited | $19.30 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Medtronic USA, INC. | $18.72 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.42 | 2019 | |
| Becton, Dickinson and Company | $18.34 | 2024 | Phasix Mesh |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $17.24 | 2025 | |
| Abiomed | $17.18 | 2024 | Impella |
| Innocoll Pharmaceuticals Limited | $16.89 | 2021 | |
| W. L. Gore & Associates, INC. | $15.37 | 2020 | |
| Merck Sharp & Dohme LLC | $14.84 | 2019 | |
| Shire North American Group INC | $14.70 | 2019 | |
| Smith+Nephew, INC. | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Parrish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.